Paper35328343
Chemical Synthesis, Pharmacokinetic Properties and Biological Effects of JM-00266, a Putative Non-Brain Penetrant Cannabinoid Receptor 1 Inverse Agonist.
Muller T and 13 others. Int J Mol Sci, 2022. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Chemical Synthesis, Pharmacokinetic Properties and Biological Effects of JM-00266, a Putative Non-Brain Penetrant Cannabinoid Receptor 1 Inverse Agonist. Papers, record 35328343. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35328343
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chemical Synthesis, Pharmacokinetic Properties and Biological Effects of JM-00266, a Putative Non-Brain Penetrant Cannabinoid Receptor 1 Inverse Agonist.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cannabinoid Receptor Antagonists | Major topic |
| Metabolic Diseases | Major topic |
| Animals | |
| HEK293 Cells | |
| Humans | |
| Mice | |
| Obesity | |
| Receptor, Cannabinoid, CB1 | |
| Receptors, Cannabinoid |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| paf/cc 14-005 | Société Francophone du Diabète | PubMed | ||
| ANR-11-LABX-0021 | Agence Nationale de la Recherche | PubMed |
Source PubMed
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9080435 | Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. | Neuroreport | 1997 | https://conductscience.org/library/papers/9080435 | PubMed |
| 2 | 22804774 | The endocannabinoid system and the brain. | Annu Rev Psychol | 2013 | https://conductscience.org/library/papers/22804774 | PubMed |
| 3 | 15864349 | Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. | J Clin Invest | 2005 | https://conductscience.org/library/papers/15864349 | PubMed |
| 4 | 17526015 | Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats. | Hepatology | 2007 | https://conductscience.org/library/papers/17526015 | PubMed |
| 5 | 22841573 | Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance. | Cell Metab | 2012 | https://conductscience.org/library/papers/22841573 | PubMed |
| 6 | 18022033 | Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. | Lancet | 2007 | https://conductscience.org/library/papers/18022033 | PubMed |
| 7 | 28256516 | SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. | Sci Rep | 2017 | https://conductscience.org/library/papers/28256516 | PubMed |
| 8 | 16291982 | Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. | N Engl J Med | 2005 | https://conductscience.org/library/papers/16291982 | PubMed |
| 9 | 19285260 | The role of the endocannabinoid system in lipogenesis and fatty acid metabolism. | Best Pract Res Clin Endocrinol Metab | 2009 | https://conductscience.org/library/papers/19285260 | PubMed |
| 10 | 12399252 | Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. | Am J Physiol Regul Integr Comp Physiol | 2003 | https://conductscience.org/library/papers/12399252 | PubMed |
| 11 | 6298542 | Interactions between phencyclidine and delta 9-tetrahydrocannabinol in mice following smoke exposure. | Life Sci | 1983 | https://conductscience.org/library/papers/6298542 | PubMed |
| 12 | 14759080 | Antagonizing the cannabinoid receptor type 1: a dual way to fight obesity. | J Endocrinol Invest | 2003 | https://conductscience.org/library/papers/14759080 | PubMed |
| 13 | 22307032 | Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice. | Gastroenterology | 2012 | https://conductscience.org/library/papers/22307032 | PubMed |
| 14 | 25796370 | Endocannabinoid signaling at the periphery: 50 years after THC. | Trends Pharmacol Sci | 2015 | https://conductscience.org/library/papers/25796370 | PubMed |
| 15 | 20664173 | Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. | J Clin Invest | 2010 | https://conductscience.org/library/papers/20664173 | PubMed |
| 16 | 16669675 | Origin of the relative stereoselectivity of the beta-lactam formation in the Staudinger reaction. | J Am Chem Soc | 2006 | https://conductscience.org/library/papers/16669675 | PubMed |
| 17 | 16569753 | Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. | J Pharmacol Exp Ther | 2006 | https://conductscience.org/library/papers/16569753 | PubMed |
| 18 | 15778743 | CB1 cannabinoid receptor-mediated modulation of food intake in mice. | Br J Pharmacol | 2005 | https://conductscience.org/library/papers/15778743 | PubMed |
| 19 | 20029379 | Peripherally acting CB1-receptor antagonist: the relative importance of central and peripheral CB1 receptors in adiposity control. | Int J Obes (Lond) | 2010 | https://conductscience.org/library/papers/20029379 | PubMed |
| 20 | 21987372 | Antagonism of peripheral hepatic cannabinoid receptor-1 improves liver lipid metabolism in mice: evidence from cultured explants. | Hepatology | 2012 | https://conductscience.org/library/papers/21987372 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42158822 | Insulin increases expression of cannabinoid receptor 1 by suppressing lysosomal degradation via ERK signaling pathway. | Int J Med Sci | 2026 | https://conductscience.org/library/papers/42158822 | PubMed |
| 41471762 | On the Question of the Regio-, Stereoselectivity and the Molecular Mechanism of the (3+2) Cycloaddition Reaction Between (Z)-C-Phenyl-N-alkyl(phenyl)nitrones and (E)-3-(Methylsulfonyl)-propenoic Acid Derivatives. | Molecules | 2025 | https://conductscience.org/library/papers/41471762 | PubMed |
| 41226265 | On the Question of the Application Potential and the Molecular Mechanism of the Formation of 1,3-Diaryl-5-Nitropyrazoles from Trichloromethylated Diarylnitropyrazolines. | Molecules | 2025 | https://conductscience.org/library/papers/41226265 | PubMed |
| 41009552 | In Silico Study About Substituent Effects, Electronic Properties, and the Biological Potential of 1,3-Butadiene Analogues. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009552 | PubMed |
| 38575140 | Resting State Brain Networks under Inverse Agonist versus Complete Knockout of the Cannabinoid Receptor 1. | ACS Chem Neurosci | 2024 | https://conductscience.org/library/papers/38575140 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CNR1 | 1268 | PubTator's text mining | https://conductscience.org/library/genes/1268 | NCBI Gene |
| CXCR6 | 10663 | PubTator's text mining | https://conductscience.org/library/genes/10663 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35328343
GET https://conductscience.org/api/papers/v1/35328343/references?page=2